(Q42830332)

8 November 2017

title

Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization (English)

1 reference

8 November 2017

0 references

Yoshizawa I

1

1 reference

8 November 2017

Soda Y

2

1 reference

8 November 2017

Mizuochi T

3

1 reference

8 November 2017

Yasuda S

4

1 reference

8 November 2017

Rizvi TA

5

1 reference

8 November 2017

Mizuochi T

6

1 reference

8 November 2017

Takemori T

7

1 reference

8 November 2017

Tsunetsugu-Yokota Y

8

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

8 November 2017

1 reference

8 November 2017

volume

19

1 reference

8 November 2017

issue

20-22

1 reference

8 November 2017

page(s)

2995-3003

1 reference

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Failure of HIV-1 protease inhibitors to fully suppress viral replication. Implications for salvage therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Toward HIV eradication or remission: the tasks ahead

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

A rational basis for mucosal vaccination against HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

pEF-BOS, a powerful mammalian expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900539-9

7 January 2021

10.1016/S0264-410X(00)00539-9

Identifiers

DOI

1 reference

8 November 2017

1 reference